Prostate cancer affects an estimated one out of every six males. Therefore it's understandable that most men want to know at least something about prostate cancer, especially as they are approaching their 40s. This article is going to touch on some of the symptoms and treatments, as well as some of the side effects that come from prostate cancer and prostate cancer treatment. This article is not intended to be a substitution for your doctor's advice, so make sure that you seek a professional opinion if you feel that you may have prostate cancer. One thing that's important to note is that you may not suffer any symptoms at all. That is why it's very important to be checked for prostate cancer frequently, and especially more so as you get older because they can find the prostate cancer before any symptoms show up at all in most cases. Some men that have prostate cancer may experience some of the following symptoms. Frequent or difficult urination, as well as a weak urine flow, erectile dysfunction as well as painful ejaculation and blood in the urine or semen. There are many different treatment options for prostate cancer and you will want to discuss these with your doctor or healthcare professional before any decision is made. A few of the choices are active surveillance, radiation or hormone therapy, chemotherapy or surgery. There are also other choices and as I said before you should discuss these with your doctor. One of the best things that you can do for your prostate is to make sure you take care of it in the first place. This may reduce your risk of prostate cancer. Just knowing some simple things such as taking vitamin E, eating plenty of fruits and vegetables and being informed about eating fats and red meat can reduce your risk of prostate cancer.
Pomegranates have long been used in traditional folk remedies to treat sore throats, inflammation, and rheumatism. And recent scientific research has suggested they are also potentially effective in both preventing and treating prostate cancer. One study, conducted on human prostate cancer cells in lab dishes, at the University of Wisconsin, found that there were dose dependant improvements. Another study at the same facility injected mice with human prostate cancer cells. These mice developed malignancies. Some mice were fed plain water, whilst two other groups of mice were given water mixed with different concentrations of pomegranate extract. Those mice that had water only had tumors that grew much faster than the pomegranate and water groups. The quantities given to the mice were comparable to that which people might get if they drank pomegranate juice on a daily basis. And whilst pomegranate juice hasn't been tested on humans with prostate cancer yet, the results are very good. The study did not indicate what aspects of pomegranate juice were responsible for slowing down prostate tumour growth. But the scientists involved did mention the antioxidant polyphenolic compounds, which are more effective than green tea and red wine. Pomegranate extract not only inhibited the growth of cancer cells, it also worked by another means - apoptosis. Apoptosis refers to a way that cells can die. Cancer growths are characterized by an uncontrolled growth of cells that do not follow the normal processes of cellular differentiation of regular, healthy cells. Cellular differentiation means that the characteristics of a cell change and get the functions that a mature, healthy cell would. For example, liver cells have specialized liver functions, as do prostate, breast, kidney, and all other types of cells. This is normal and healthy. In tumour growths, although some cells fully differentiate, many only differentiate partially, and some not at all. And the tumors which have more undifferentiated cells grow faster. So, inducing cellular differentiation is one approach to cancer treatment. The other two ways that doctors and researchers try to treat cancer is by causing the death of cancerous cells. They do this through apoptosis, mentioned above, and necrosis. In apoptosis, cell death is programmed into the cell when it is 'born'. So the cell dies in a more natural way that is less destructive on its environment. By this I mean it doesn't cause inflammation and the damage associated with it to neighboring cells that may be healthy. Cells die either when they reach cellular old age or when their death benefits the body as a whole. Necrosis, on the other hand, does cause inflammation. Generally, prostate cancer grows very slowly, although it is unpredictable and can grow quickly and spread. References: 1. John Boik, Cancer and Natural Medicine (Oregon Medical Press, 1996) 2. Australian Healthy Food, March, 2006 3. nutraingredients-usa/news/ng. asp? id=62811 4. nutraingredientsusa/news/ng. asp? id=62811
Over the past few years Prostate Cancer has been targeted by health authorities as the largest hidden killer of men over 45 years of age. Although there have been advances in education and general public awareness, men are still demonstrating reluctance to acknowledge the need for vigilance in their everyday lives. There are a number of ways that men can reassure themselves however. Here is a list of facts and suggestions collated from a number of sources that you should know about. One in every 6 men will suffer from prostate problems in their lives. So there is no need to feel isolated or a victim. Just take action and get to a doctor quickly at the first sign. It is almost certain that quick action will lead to successful recovery. The sooner you visit your doctor and get referred to a Urologist the better your chances of successful treatment. There is hope for the future. In 2002, scientists at Liverpool University in the UK isolated the gene that promotes the spread of prostate cancer. This information is still being explored to hopefully produce new drugs which will assist treatment of Prostate cancer outside of the normal Chemotherapy regimes currently in use. Dietary habits are the common thread in most of the literature about prostate cancer. • Dairy products should be eliminated and replaced by soya. Just a couple of glasses of soy milk a day can have dramatic effects. • Lyocopene contained in tomatoes is another factor showing up in studies as an effective preventative element of a prostate cancer fighting diet. Eating one moderately sized tomato a day also provides approximately 4 mg of lycopene. Other tomato products, such as an 8-ounce portion of tomato juice or tomato paste may provide up to 25 mg of lycopene. See naturalhealthlive/Lycopene. html • Other fruits and vegetables are also recommended, such as avocadoes, pumpkins, beans and carrots and green leafy vegetables like spinach. • Garlic, which seems to pop up in every preventative healthy diet plan is also recommended as it contains allicin, which decreases the proliferation of cancer cells. • Selenium which is found in garlic, tomatoes, and broccoli has also been shown to be effective. Cut back on salt and seasonings as these have been linked to cancer. Finally, green tea is a popular choice as a beverage so drink at least 6 cups a day. All in all there are plenty of reasons to be positive about controlling the risk of contracting prostate Cancer. A healthy diet as outlined above, coupled with most others advocated by Dietician everywhere, will dramatically reduce your concerns and help you lead a normal healthy long life.
Prostate cancer is the most common cancer among American men after skin cancer, according to the National Cancer Institute. Based on this statistic, most people might assume that the majority of American men are well educated about how best to fight prostate cancer, where to turn for more information and what support group an uncle or golf buddy relied on during their respective battles with the disease. Unfortunately, this is not the case. While women regularly host breast cancer awareness and fund-raising walks across the country, men have been less proactive on matters related to their health, including essential measures such as soliciting second opinions and researching treatment options. The result of this passive approach is that the average man does not always make good, informed decisions about his own health care. A new program is encouraging men to alter their approach to health care, at least when it comes to battling prostate cancer. Us TOO International Prostate Cancer Education and Support Network, along with Y-ME National Breast Cancer Organization, have founded the "Partner's Program" to help men with prostate cancer and their partners face the diagnosis together, encourage them to seek information regarding treatment options, and ultimately, make more well-informed treatment decisions. This program clearly responds to an unmet need. Recently, an Us TOO - and Y-ME-commissioned survey found that, although the majority of men with prostate cancer have heard of both surgery and radiation as treatment options, up to 38 percent don't know that other treatments, such as hormonal therapy, even exist. Even more alarming, less than 50 percent of men with prostate cancer take the time to get a second opinion on their diagnosis or proposed treatment. These facts are sure to concern anyone who loves a man at risk of developing prostate cancer. The good news for wives and partners is the survey found that men don't want to face prostate cancer treatment choices alone, making a resource like the "Partner's Program" attractive for both men and women. While men are not typically as open as women on subjects such as prostate cancer, the survey found that almost 70 percent of men age 50 and older indicated that they would like their partner to play an active role in the process of choosing an appropriate course of therapy. Now, with the help of the "Partner's Program," the average American man may become more proactive about his health.
Prostate cancer as one of the most common types of cancer in men according to the American Cancer Society. Fortunately if caught early, the prognosis is good. Even better than treating it, is of course, avoiding it altogether. The search for the cause of prostate cancer is ongoing and a recent study was recently completed. An eight year study of 29,361 men has just been completed. The study examined the impact of antioxidant supplements on the rate of prostate cancer. "There has been definite interest in their use, based on a few earlier studies that have been done" said lead researcher Richard B. Hayes, senior investigator in the division of cancer epidemiology and genetics at the U. S. National Cancer Institute. Reporting in the Feb. 15 issue of the Journal of the National Cancer Institute, Hayes' team calculated the risk of prostate cancer for 29,361 men aged 55 to 74, all of whom were participants in the Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial. Some of the data that was analyzed included the amount of common antioxidant supplements including vitamin C, beta carotene, and vitamin E. Some of the men had been taking these supplements for many years prior to the study. Over the total eight year study period, 1,338 men developed prostate cancer. The results indicate that the use of antioxidant supplements had no positive impact on the risk for prostate cancer for most nonsmokers. Beta carotene supplements did have a positive impact among men that had low dietary intake of beta carotene. Vitamin E did have a positive impact for smokers according to the research. This was consistent with previous trials. Although the three supplements studied in this trial showed little help in preventing prostate cancer, previous trials that examined other supplements did show very encouraging results. Fish oils, which contain EPA and DHA, were found to reduce prostate cancer by 11% in men that consumed about 470 mg./day. Selenium has been found to cut prostate cancer in half. Over five clinical trials have supported this. It is recommended that men take a 200 micrograms of selenium daily.
: Copyright 2006 Radoslaw Pilarski Etiology Etiology of prostate cancer development is not completely known. Factors that can influence the creation and development of this type of cancer include: genetic factors – increase in risk of falling ill among men with a positive family history regarding the prostate cancer. Mutations of suppressor genes are also taken into consideration (p53) dietetic factors – food rich in saturated fatty acids probably increases the risk of falling ill whereas the consumption of soya and rice may have a beneficial protective effect racial and geographical factors – Afro-Americans are 100% more likely to fall ill, whereas the lowest death rate is reported in Japan and in China occupational factors – cancerogenous influence of heavy metals and toxins infectious factors – viral infection may lead to/ be the cause of anaplasia of adenocyte cells of prostate Histopathologically, 95% prostate cancer cases occur in the form of adenocarcinoma. Other types (primary intracellular cancer, squamous carcinoma, anaplastic carcinoma, and sarcoma) are rarely met. Adenocarcinoma usually develops in the peripheral area of the prostate (85%), in the transition area (25% ) and in the central area (5%). Symptoms In symptomatology of the prostate cancer, 4 clinical forms are distinguished: 1) visible form with distinct pathological symptoms 2) latent form (carcinoma latens) with no distinct pathological symptoms found 3) hidden form (ca occultum) which is detected in the case of distinct ailments caused by the existence of remote metastases, however changes in prostate are not found in the course of per rectum examination 4) accidentally detected form - based on histopathological test of the gland that was removed because of prostate overgrowth, or based on biochemical tests (PSA) During the development of prostate cancer, an induction phase that lasts about 30 years which is clinically invisible can be distinguished. During the next stage - in situ phase (5-10 years) and invasive phase (1 year), ailments connected with the local growth of tumour start to appear. During this period, symptoms connected with sub bladder obstacle appear including mainly: - pallakiuria - nycturia - weak urine stream - painful vesical tenesmus - impression of incompletion of bladder emptying The above-mentioned symptoms are typical of cancer and in some cases they may suggest mild overgrowth of prostate, or neurogenic or athermatous bladder disorders. During the dissemination phase (about 5 years), prostate cancer develops continuously infiltrating surrounding organs, such as: urinary bladder, rectum, ureters, pelvic walls and leading to urinary retention in kidneys and to secondary failure of function. Ailments typical for this period include: - haematuria - dysuria - urinary incontinence - erection disorders - aches of perineum, lumbar area and anus - haematospermia Metastases spread through the lymphatic vessels and the vascular system. Symptoms caused by the existence of remote metastases are as follows: - osteodynia and pathological fractures - pressure symptoms and spinal paralysis - lymphadema of limbs - clotting disorders - cachexy - coma DIAGNOSTICS In order to diagnose the prostate cancer, patient should undergo per rectum tests (DRE), PSA concentration (prostate specific antigen) in blood serum should be determined, ultrasonography per rectum examination (TRUS - transrectal ultrasound) should be done and if there is a suspicion of prostate cancer, histopathological test of the material obtained through a per rectum thick-needle biopsy done under the ultrasound control should take place. Histopathological test is the only test that confirms the presence of cancerous cells in the prostate gland area. DRE, which is an examination of sensitivity of 80% sensitivity and of specificity of 60%, enables to seize changes in the area of the prostate such as consistency change, palpable nodules and hardenings. It is the base for sending a patient to a diagnostic biopsy. At present, it is believed that cytological diagnosis achieved through a fine-needle biopsy is not sufficient to make a right diagnosis. It results from the fact that the assessment according to Gleason’s classification is an important prognostic factor for the prostate cancer (see: prognostic factors). That is why a thick-needle biopsy is performed. Ultrasound use enables to take precise samples from suspicious foci. If there are no changes in TRUS picture, "sextant biopsy" is done (samples got for several places). Recommendations for the biopsy of prostate gland: 1) palpable suspicion of the prostate cancer 2) PSA value over 15ng/ml regardless of DRE or TRUS tests 3) PSA value between 4 and 15 ng/ml with abnormalities detected during DRE or TRUS tests 4) PSA value exceeds the norm for a given age in the case of a positive family history regarding the prostate cancer Recommendations for TRUS: 1) PSA between 4 and 12 ng/ml with abnormalities detected 2) questionable result of DRE test 3) necessity of a thick-needle biopsy Other diagnostic tests, such as CT and urography are not routinely performed because their value is questionable as far as the assessment of local stage and invasion of adjacent lymph nodes is concerned. Nowadays, magnetic resonance tomography done using transrectal coli (endorectal coil MRI - ERMR) to observe the prostate arouses great interest. Despite the increased sensitivity of the degree of the local stage, costs of the test do not allow for its routine use in the prostate cancer diagnosis. Scintigraphy of the skeleton is the most sensitive test (97%) in bone metastases detection. It is assumed that a patient with PSA under 10 ng/ml does not undergo scintigraphy because the probability of metastases is low. Screening: Screening: It is recommended that patients aged over 50 should undergo per rectum tests and PSA level tests every year. PROGNOSTIC FACTORS: Three groups of prognostic factors can be distinguished in the case of the prostate cancer: 1) development stage according to TNM 2) differentiation degree of the cancer based on the classification of Gleason and Mostofi 3) PSA level (prostate-specific antigen) in serum TNM classification Preoperative assessment of the stage of the prostate cancer is made based on the above-mentioned tests. T-stage: primary tumour Tx - primary tumour cannot be assessed T0 - no evidence of primary tumour T1 - clinically unapparent tumour; not palpable or visible by per rectum imaging T1a - incidental tumour found in histopathological tests after transurethral resection of the prostate or after operational adenectomy: found in 5% or less resected tissue T1b - as above; found in more than 5% resected tissue T1c - tumour identified histopathologically by a needle biopsy (because of high PSA) T2 - tumour confined within the prostate gland T2a - tumour involves less than half of one lobe T2b - tumour involves more than half of one lobe only T2c - tumour involves both lobes T3 - tumour extends through the prostatic capsule T3a - extracapsular extensions (unilateral) T3b - extracapsular extensions (bilateral) T3c - tumour invades seminal vesicles T4 - tumour is fixed, invades adjacent structures other than seminal vesicles T4a - tumour invades bladder neck and/or external sphincter and/or rectum T4b - tumour invades levator muscles and/or pelvic wall N-stage: regional lymph nodes Nx - regional lymph nodes cannot be assessed N0 - no regional lymph node metastases N1 - metastasis to a single regional lymph node with the diameter under 2cm N2 - metastasis to a single regional lymph node with the diameter > 2cm but < 5cm N3 - metastases to regional lymph nodes with the diameter over 5cm M-stage: remote metastases Mx - remote metastasis cannot be assessed M0 - no remote metastases M1 - remote metastases M1a - non-regional lymph nodes M1b - bones M1c - other sites According to Whitmor-Catalon classification, grades A, B, C, and D correspond to T1, T2, T3 and T4 of TNM classification respectively. Degree of cancer differentiation: Degree of differentiation is defined according to 2 classifications: by Mostofi and by Gleason. Mostofi’s classification uses a 3-grade assessment of differentiation dependent on the degree of cell anaplasia – grading (G1-G3). The higher grade, the lower differentiation of cancer tissue, the greater atypy and at the same time, malignancy. In the case of a 10-grade Gleason system, the two extreme histological images in the preparation are assessed and then, added to produce a final grade. PSA is a proteolyctic enzyme responsible for sperm melting. It is mainly produced by glandular epithelium, it might be also produced in organs such as salivary glands, pancreas and mammary gland and by clear cell carcinomamonly used norm is the following: 0-4 ng/ml. Such concentration of PSA is found among 97% of men over 40. The level over 12 ng/ml is always connected with pathology. Difficulties with diagnosis are found among patients who have this level between 5-10 ng/ml because it may both stem from the prostate cancer or a mild overgrowth of the prostate, which causes the necessity of diagnostic methods use, such as TRUS. This test makes it possible to determine PSA density (PSAD - PSA density) - PSA concentration converted to prostate volume unit. It should be under 0.15 ng/ml/g. In the case of prostate cancer differentiation and mild overgrowth of prostate, free to total PSA (PSA F/T) is used. If it is over 20%, one may assume the presence of cancerous cells in the gland. PSA level does not correlate well enough with the natural development of the prostate cancer. However, it is useful as a prognostic factor after the treatment applied and in prognosis determination. However, high final levels indicate low survival rate. TREATMENT Proceeding strategy in patients with the prostate cancer depends on the degree of histological malignancy, the degree of local stage of development, coexisting diseases and age of a patient. There are many controversies as far as the choice of treatment is concerned. Radical treatment is possible in T1, T2 and N0 and Mo stages. In advanced cases (T3, T4, N-+, M-+), the procedure is restricted to delay the cancer progression and mitigate its effects (palliative treatment). Surgery treatment - radical prostatectomy The surgery consists in the prostate gland removal together with spermatic vesicles and adjacent tissues. Surgery is done through retropubic, transcoccgeal, perineal approach or through laparoscopy. Lymphadenectomy constitutes an integral part of the surgery. If the approach makes it impossible to remove the gland and lymph nodes (perineal approach) at the same time, a separate surgery is carried out. It precedes the operation proper. It is believed that cancerous cells found in the removed lymph nodes are the reason why prostatectomy cannot be performed. Invasion of lymph nodes to a certain extent suggests PSA level over 40ng/ml together with grade >7 in Gleason’s scale. Recommendations for surgery: 1) cancer limited to the prostate gland (T1BN0M0Gx - T2N0M0Gx, T1AN0M0G3) 2) predictable life span over 10 years 3) consent of a patient If positive chirurgical margins, capsule infiltration or cancerous changes in the removed lymph nodes are found in postoperative microscopic assessment, the prognosis is worse – such patients are qualified for palliative treatment. The death rate in the postoperative period does not exceed 5%. Intraoperative complications first of all include: bleeding from Santorini’s plexus, damage of rectum wall, underpinning of ureter. Early complications after surgery: thrombotic and embolic complications (phlebothrombosis 3-12%, lung embolism 2-5%) and lymphocele. Late postoperative complications after prostatectomy include: urinary incontinence, erection disorders and narrowing of urethro-vesicular junction). Radiotherapy Apart from radical prostatectomy, radiotherapy is an effective method of treatment for patients with regional advanced prostate cancer. In radical treatment, the most frequently done using radiation from external sources, the dose of 50-70 Gy in fractions continuing over 5-7 weeks are given. T1ABC - T2ABCG1 and T1ABCG2 stages require radiation limited to the prostate. In other cases, area that is radiated includes adjacent lymph nodes as well. In recent years, multidimensional imaging with CT (3D conformal radiotherapy) is used in the treatment planning. Brachytherapy constitutes another method that is used. Recommendations for radical radiotherapy of the prostate: 1) prostate cancer confined with the organ 2) sufficiently long predictable survival span 3) no disorders in lower urinary tract 4) no disorders in rectum and colon 5) consent of patient to carry out treatment 6) early complications of radiation energy treatment (30% of patients) include dysuria, haematuria, diarrhoea, rectal tenesmus, inflammation of large intestine and rectum. Among later complications (11% of patients) chronic diarrhea, ulceration of rectum, bladder neck stenosis and intestinal fistula stenosis are observed. Control of patients after radical prostatectomy and radical radiotherapy: - per rectum test, PSA level in blood serum each 3 months. PSA level should be lower than 1 ng/ml (after radical prostatectomy it should be near to 0). Increase over 0.5 ng/ml within a year means failure of radiotherapy. Hormonotherapy Hormonal therapy is mainly used as palliative treatment in advanced prostate cancer. It makes it possible to stop symptoms of the disease for some time and then, further progression of the disease takes place. Nowadays, the use of therapy in pulsation system is considered as it delays the development of hormone-resistant cell clones. Ways of hormonal treatment include: 1) surgery castration (orchidectomy) 2) anti-androgens a) non-steroid b) steroid 3) analogues LH-RH 4) oestrogens, progestogens, inhibitors of androgens synthetase Hormonotherapy by analogues LH-RH is also recommended before planned radical radiotherapy. In the case of hormone-resistant cancer, treatment with combined cytoctatic and hormone (estramustine), however without significant effects. PROGNOSIS Prognosis depends on the development stage, degree of differentiation and PSA level (see: prognostic factors). In T1A, B stage prognosis is good. 10-years survival 35-80%, death rate of the cancer 7-30%. In T2 stage, overall survival equals 34-85%, death rate equals 8-26%. In T3 stage, among patients who undergo non-invasive treatment for 9 years, overall death rate equalled 63%, from cancer – 30%. Depending on the degree of cancer differentiation, 10-year survival of patients is the following: for cells well differentiated - 81%, for cells moderately differentiated - 58% and for cells poorly differentiated - 26%.
The commonest form of cancer in the United States today is skin cancer but, to many people's surprise, prostate cancer is the second most frequently seen type of cancer and results in some 30,000 deaths each year. So just what is prostate cancer? The human body starts its life as a single cell which divides repeatedly to form new cells. As cell division continues so the newly created cells, acting as the building blocks of the human body, form themselves into walls of tissue creating the various parts that we recognize as the human body. This is not however the end of the process as, throughout our lives, our bodies change constantly with old cells wearing out and dying and other newer cells continuing the process of division to replace them. Occasionally however this process of division does not follow the pattern that it should and a cell divides incorrectly, forming two cells which do not carry the correct information to function normally. At the same time this frequently sets off a chain reaction so that these cells in turn begin to divide, forming further faulty cells. This, in simple terms, is the basis of all cancers and, where faulty cell division takes place in the prostate gland, then the result is prostate cancer. The prostate gland, which is about the size of a walnut, sits between the bladder and the rectum and partially surrounds the urethra (the tube which carries urine from the bladder) and its main function is to produce and store a clear fluid which makes up about thirty percent of male semen. Although we tend to think of cancer whenever the prostate is mentioned, there are in fact numerous other problems that can affect the prostate gland, many of which can be quite easily treated. Prostate cancer is rarely seen in men under the age of 40 and, although cases are seen between the ages of 40 and 65, the vast majority of prostate cancer cases arise in men over the age of 65. In many cases however the progress of the disease is slow and early stage prostate cancer often carries few if any noticeable symptoms. For this reason many men can suffer from prostate cancer for years before it is diagnosed and the average age at which diagnosis is made in the United States is currently 70. If caught in its early stages prostate cancer can be successfully treated either by surgery or radiation therapy (radiotherapy) and, while such treatment can often leave its mark in terms of ongoing problems with urination or a degradation or loss of sexual function, the cancer will often not return. Problems arise however if prostate cancer is more advanced at the time of diagnosis and has already spread into neighboring tissue and bone, or has been carried to other parts of the body, usually through the lymphatic system. Here a combination of surgery, radiation therapy and possibly hormone therapy can certainly help in treating the problem but the cancer will often reappear. Perhaps the biggest problem lies in the fact that, in terms of their general health and sexual health in particular, men have traditionally suffered in silence and will only venture into the doctor's surgery when they are at death's door. This fortunately is starting to change in our modern society, even if only slowly, and as an increasing number of men turn to their doctor when they first suspect that something might be wrong, rather than waiting until they know something is wrong, then perhaps the early diagnosis of prostate cancer will result in fewer deaths each year from this treatable disease.
With such widespread diseases as prostate and various other forms of cancer, there are concerns which eventually arise about the treatments and tests for such illnesses. Because such illnesses are so prevalent in developed countries, diseases like cancers and diabetes are widely studied by research institutions all over the world in hopes that there will be better cures and quicker tests to determine if someone has the illness or not. However, by developing such treatments, preventative measures and genetic tests, people fall into the problem of what constitutes morality. For illnesses like prostate cancer, morality is on the verge of being sent to the wayside in an effort to allow high risk individuals to be tested for the prostate cancer gene long before they reach the age in which prostate cancer will spring up within their bodies. Perhaps the biggest debate over prostate cancer morality is whether or not scientists should develop early screening tests for the illness in high risk patients. Due to the extremely high genetic correlation between those affected by prostate cancer and the probability of their children getting the disease when they are older, a genetic test would be an excellent way to help people realize if they will have prostate cancer in the future or not. Unfortunately for the technologies which could ultimately screen for prostate cancer, morality soon enters the debate. If people find out when they are young that they will have a high risk for prostate cancer at age sixty or so, they may have a slightly traumatic experience growing up and feeling that they will die at around age sixty – especially if there is no cure for prostate cancer by that time. Furthermore, they would have difficulty finding health insurance – as no self respecting insurance agency will want to insure a person who will be catching a costly disease at age sixty. These are two major concerns from a point of prostate cancer morality. On the opposite side of the argument, however, people who say that prostate cancer morality should take a back seat to scientific advancement proclaim the benefits of early genetic testing. People should be aware of the status of their health. If more people were to receive blood tests to determine if they are at risk for prostate cancer, they would go get more prostate exams which would in turn lower the mortality rate for prostate cancer. After all, it is pretty difficult for those who support prostate cancer morality to argue against less people dying. The whole battle between prostate cancer morality and the necessary science to help cure people will certainly turn into a raging debate in the future. Ultimately, the outcome will determine how well we handle other emerging diseases and whether or not we will do whatever it takes to combat them.
Prostate health is one of the most important aspects of a man’s health. Prostate health is something that should be treated with a balanced diet your whole life. Prostate cancer is VERY serious and will kill you if not diagnosed early and treated. Prostate cancer is a condition where prostate cells grow exponentially and out of control. It is the most common cancer associated with men, and can lead to many complications, one rather large one being that you die. Since prostate cancer is one of the most common forms of cancer in men, every man should consider trying to improve the health of this vital gland naturally through diet and supplements. The idea of eating for a healthy heart is now medically accepted but the concept of eating for a healthy prostate is revolutionary. Afflictions of the prostate are most commonly found in developed countries whose dietary habits focus on red meat and dairy products. Eastern males eat many more yellow, orange, red and green vegetables (such as red, yellow and green peppers, broccoli, spinach, etc. A recent Harvard study, among others, found that diets high in lycopene-rich tomatoes, tomato products and other lycopene-rich sources have been shown to be associated with a lowered risk of developing prostate cancer. Dietary fiber derived from beans, lentils and peas in high quantities have been associated with decreasing prostate cancer risks while promoting prostate health. The main component associated with prostate cancer is fat. A diet low in animal meat may decrease your risk for developing prostate and other cancers. Maintaining a healthy prostate is easy enough these days with all of the dietary supplements and herbal pills now available. Each year thousands of men are treated for inflamed prostates, in most cases those cases of prostatitis could have been prevented with the help of supplements for prostate health. Supplements for prostate health are not meant to cure disorders, but they can help strengthen a man's resistance against these conditions. Most supplements for prostate health are found in ordinary natural foods that people can easily get their hands on. Herbal remedies have long been found effective as supplements for prostate health. In the past few years, supplements for prostate health have been made available to help men minimize their chances of developing any of these disorders. Even though these supplements cannot cure cancer, they can help in developing the defenses of men against prostate disorders. In fact, a range of dietary supplements and herbal medicines offers new ways to prevent or treat prostate disease, and cancer in general. Prostate health is simply nothing to ignore and finally… you don’t have to. Prostate health is one of the most important concerns for men, and each man should have a yearly check of their prostate health after a certain age. Natural prostate health is the best choice that many men are making today to ensure their health, since natural health is about taking care of your body as a whole. Prostacet is a super prostate formula and the best supplement to give your body all that it needs to help you in reducing your risk for prostate cancer.
Introduction Prostate health is important to men's sexual health. The prostate is part of the male reproductive system. Prostate health is one of the most important concerns for men, and each man should have a yearly check of their prostate health after a certain age. Prostate health is one of the leading concerns for American men. Prostate cancer Prostate cancer is a malignant tumor that arises in the prostate gland. Prostate cancer is the most common nonskin malignancy and the second leading cause of cancer deaths in United States males. Prostate cancer is one of the most common cancers affecting older men in developed countries and a significant cause of death for elderly men (estimated by some specialists at 3%). Prostate cancer risk can be decreased by modifying known risk factors for prostate cancer, such as decreasing intake of animal fat. Prostate-specific antigenSerum prostate-specific antigen (PSA) levels may be measured to help determine if lower urinary tract symptoms (LUTS) may be due to prostate cancer. Treatment Treatment options should be studied closely by all men diagnosed with prostate cancer. Treatment involves identifying the cause of the symptoms, which may include bacteria, or scar tissue in the passage to the urethra that has resulted from an injury. Because all treatments can have significant side effects, such as erectile dysfunction and urinary incontinence, treatment discussions often focus on balancing the goals of therapy with the risks of lifestyle alterations. Treatment for prostate cancer may involve watchful waiting, surgery, radiation therapy, High Intensity Focused Ultrasound (HIFU), chemotherapy, cryosurgery, hormonal therapy, or some combination. Treatment Choices for Men With Early-Stage Prostate Cancer describes the treatment choices available to men diagnosed with early-stage prostate cancer and examines the pros and cons of each treatment. Conclusion Prostate health is extremely important, as prostate cancer and other related medical conditions are common among men. Prostate health is a major concern for most men, especially those over the age of 50. Prostate issues are mostly one of main reasons for mens impotence or so called erectile dysfunction. Prostate health is important to men's sexual health.
There are sixteen different supplements that you can add to your prostate health diet. But let start with the ones you should start using right away. The first one you should start using is beta-sitosterol. Beta-sitosterol Beta-sitosterol is the main active ingredient in the herbs saw palmetto and pygeum. Both of these herbs do not have enough beta-sitosterol to be of real value in giving you prostate health. Now, beta-sitosterol, which can be obtained from sugar cane pulp, can be purchased in capsule doses of 300 - 600 mg, which gives you an effective dose to eliminate your enlarged prostate. Pygeum can only provide around 30 mg and you need upwards of 600 mg daily. Go to the Internet to find a good beta - sitosterol price and quantity. Flax Seed or Fish Oil The nutrient to use for the best prostate health diet is flaxseed oil. Flax seed oil contains more omega-3 than omega-6 and so it makes it a good source of omega-3. The more omega-6 use, from olive oil and other vegetables oils, the more prone you will be to prostate cancer. This is not the case with omega-3 oil and this has been verified through clinical studies. Omega-3 protects the prostates cells and has anti-inflammatory properties. Using fish oil can also be a better choice than flax seed oil since your body digests it better. Use 1 - 2 grams of flax seed or fish oil per day. Soy Isoflavones Soy Isoflavones have been shown in clinical studies to have good effects on your prostate and should be added to your prostate health diet. These isoflavones are flavones and contain no photoestrogen so the have no estrogen effects in the body. The active ingredients in the isoflavones are genestein and daidzein. Buy a brand that has up to 40 mg of isoflavones Use this quantity daily. Ionic Minerals The prostate needs minerals. Adding these to your prostate health diet is critical. You cannot have good prostate health without plenty of minerals and your regular diet cannot supply what you need. Use the Ionic Minerals, which are liquids, but not the colloidal minerals. Ionic Minerals are absorbed immediately into your blood stream soon after they enter your mouth. In addition to these ionic minerals, you need to make sure you get plenty of zinc and selenium. The prostate has more zinc than any other part of the body. So take 15 - 20 mg per day and not to exceed 40 mg. Vitamin D Vitamin D is another critical vitamin that you want to make sure you get plenty of. If you are out in the sun a lot, then you will not need to supplement with this vitamin. Otherwise, use up to 800 IU of this vitamin. Vitamin E This is the next most important Vitamin you should supplement with. Use up to 400 mg per day of the natural mixed tocopherols. Clinical studies have shown that vitamin E can reduce and suppress prostate cancer cells. There you have it. Use, beta sitosterol, isoflavones, minerals, vitamin D, and vitamin E in your prostate health diet and see improvements in your prostate symptoms and health.
Prostrate cancer is the disease which is found more in men than women. It can be cured if it is found in the initial stage, so no need to get tensed you can come out of it without any harm. Prostate cancer is a disease in which cancer develops in the prostate, a gland in the male reproductive system. Cancer cells may spread from the prostate cancer to other parts of the body, especially the bones and lymph nodes. This cancer develops most frequently in men over fifty. However, many men who develop prostate cancer never have symptoms, undergo no therapy, and eventually die of other causes. When cells in the prostate grow abnormally, they form multiple small cancerous tumors. If the cancer is left untreated, it will at some point metastasize and begin to spread to other organs in the body via the bloodstream and lymphatic system. Prostrate Cancer: Who's at Risk 1.Age: Prostrate cancer is got to the men who are at the age above 50. 2.Family history: A man is at higher risk if the father or brother is suffering from this disease. 3.Race: This disease is more in African American men than in other men. 4.Diet and dietary factors: The diet in the animal fat may create for higher risk for prostrate cancer and the diet in the vegetables and fruits may decrease the risk for prostrate cancer. What causes prostrate cancer. While nobody knows what causes prostate cancer, there are some recognised risk factors: · Risk increases over the age of 50 years. When the man starts growing older he gets attacked with this. Prostate cancer is rare in younger men. · If your father or brother had prostate cancer, then can get at it is at high risk increases. If they had it at a young age, your risk is even higher. · High fat, lots of red meat. Countries with low fat and low meat diets have low levels of prostate cancer. · Being overweight is a major risk factor for all cancers. Recognising symptoms * A need to urinate frequently, especially at night; * Difficulty starting urination or holding back urine; * Inability to urinate; * Weak or interrupted flow of urine; * Painful or burning urination; * Difficulty in having an erection; * Painful ejaculation; * Blood in urine or semen; or * Frequent pain or stiffness in the lower back, hips, or upper thighs. Treatment of prostate cancer Prostate cancer treatment generally depends on several different factors present in each case of the disease. The type of prostate cancer, the size of the cancer, its location, as well the health condition of the patient all play a part in how prostate cancer will be treated. Often, prostate cancer is a slow progressing disease although this is not always the case, but this is no excuse to procrastinate. Cure rates are very high if treatment begins while the cancer is in its early stages, but drop steeply once the cancer metastasizes. Get tested today - no pain, much gain! Obviously, the sooner prostate cancer is found and diagnosed, the better the chance of recovery. Success in prostate cancer treatment will depend on a number of factors including the progression of the disease upon discovery, where the cancer is located, the age and health of the patient, and how it reacts to treatment. Treatments other than conventional western medicine are usually considered "alternative therapies." They usually are not backed by scientific data but by years of use. Some alternative therapies date back thousands of years. These medicines do not have any harm at all they are natural treatments.
The prostate is a small, walnut-shaped sex gland in men that produces the seminal fluid, which nourishes and transports sperm. The growth of the cells in the prostate gland is stimulated by the male sex hormone called testosterone. Though its causes are unknown, prostate cancer is a frightening prospect for men. This cancer threatens not just their lives, but also their sexuality. Possible consequences of treatment (even if the treatment has been successful in saving a person’s life) include erectile dysfunction and bladder control problems. Prostate cancer progresses very slowly and the early stages show little or no symptoms. If detected early, effective treatment with minimum side effects is possible. Once the cancer spreads (metastizes) treatment becomes more difficult. A man’s vulnerability to prostate cancer increases with age. Most often, prostate cancer is detected very late and people who lose their lives do not die from prostate cancer, but die WITH prostate cancer. As the cancer develops, it eventually squeezes the urethra, which surrounds the prostate. This is when signs and symptoms begin to appear: -Urgency in urination -Difficulty in starting urination -Dull, persistent ache in the lower pelvic area -Painful urination, a very slow flow (almost like a dribble) -Intermittent urine flow, and a sensation that the bladder is not empty -Frequent urination, sometimes including blood -Painful ejaculation -Persistent pain in the bones, lower back, hip and thighs -General ill health, loss of appetite, and decline in weight If the cells from the cancerous prostrate break away, the cancer will spread. Most commonly, prostate cancer spreads to the lymph nodes, bones in the hips or the lower back, lungs, and sometimes even the brain. Risk factors: The risk of prostate cancer increases with age. As with almost any other cancer, heredity also plays a key role. For reasons unknown, African-American men seem to have a higher risk of prostate cancer. A fat-rich diet and sedentary lifestyle also contributes to the risk. Fat causes an increased production of testosterone, which may in turn lead to the development of cancer cells. High levels of testosterone mean higher chances of developing prostate cancer. Therefore men who suffer from hypogonadism, or have been undergoing long-term testosterone treatments are at risk. A vasectomy may also result in prostate cancer, though there is no conclusive proof of this. A routine screening test may reveal the beginnings of prostate cancer. A DRE (Digital Rectal Examination), which involves inserting a gloved finger into the rectum, helps the doctor to examine the prostate. Any change in shape or size of the gland may mean trouble. A prostate-specific antigen (PSA) test analyzes a blood sample for the levels of PSA. If a higher than normal level is detected, a prostate infection or cancer may be suspected. A transrectal ultrasound helps to further evaluate the prostate using sound waves. If initial tests produce positive results, a prostate biopsy may be done to verify the presence of cancer. If cancer is confirmed, the next step is to investigate the spread of the cancer. A bone scan, CT scan, and Ultrasound scan may be used for this. The mode of treatment directly depends on how aggressive the cancer is. For most men, a combination of treatments (surgery, radiation paired with hormone therapy, chemotherapy) may prove effective. The best way to reduce the risk from prostate cancer is to eat a diet rich in fiber and low in fat. Regular exercise also helps.
: Prostate health is an important topic on the minds of many today. Prostate health is extremely important, as prostate cancer and other related medical conditions are common among men. Prostate cancer symptoms are similar to those for prostatitis and BPH and can also include blood in urine or semen, painful ejaculation and constant pain in the lower back, pelvis or upper thighs. With supercharged saw palmetto, powerful antioxidants and a list of proven prostate supporters, Prostacet is the most comprehensive formula available. Each year thousands of men are treated for inflamed prostates, in most cases those cases of prostatitis could have been prevented with the help of supplements for prostate health. Maintaining a healthy prostate is easy enough these days with all of the dietary supplements and herbal pills now available. In the past few years, supplements for prostate health have been made available to help men minimize their chances of developing any of these disorders. Supplements for prostate health are not cures, they are habits and nutrients that can help improve a man's prostate health and thereby narrow his chances of acquiring prostate-related disorders such as prostatitis, enlarged prostate and even cancer. Supplements and food sources rich in antioxidants (vitamin E and selenium) have been shown to control cell damage and may prevent prostate cancer. Herbal remedies have long been found effective as supplements for prostate health. Some of the most common ingredients in prostate supplements are herbs like saw palmetto and pygeum. Good supplements, such as Prostacet, combine different ingredients proven to support good prostate health. Afflictions of the prostate are most commonly found in developed countries whose dietary habits focus on red meat and dairy products. To maintain the health of the prostate gland, experts have claimed that excessive intake of animal-derived foods such as red meat and dairy products should be avoided. While, products like saw palmetto berries and lycopene may help naturally improve an enlarged prostate. The difference now is, we've become a nutritionally advanced culture who has learned more and more about natural supplements and products that can help us achieve and maintain health much longer than we used to, as well as to eat the right foods that will make our organs function at peak levels well into late ages. A healthful diet consisting of vegetables, fruits, whole grains and soy products along with vitamin and herbal support can have a beneficial effect on the prostate gland. Prostate health is a concern for men of all ages and this increases as we grow older. A healthy prostate is also vital to proper sexual function, so most men take the health of their prostates very seriously. For men, particularly those aged 45 and above, maintaining a healthy prostate is necessary. Since prostate cancer is one of the most common forms of cancer in men, every man should consider trying to improve the health of this vital gland naturally through diet and supplements. Prostacet is a super prostate formula and the best supplement to give your body all that it needs to help you in reducing your risk for prostate cancer.
An estimated 230,000 American men will be diagnosed with prostate cancer in 2005 - enough to fill a baseball stadium four or five times. But research shows that a partner's involvement in health care decisions is positively associated with better outcomes for prostate cancer patients. Ali Torre, wife of legendary baseball manager and prostate cancer survivor Joe Torre, knows firsthand the important role that family members play in helping a person with prostate cancer make treatment decisions. "I learned through my husband's experience with prostate cancer that assembling a multidisciplinary team of medical specialists, including a urologist, a radiation oncologist and a medical oncologist, is the best way to ensure that all treatment options are fully explored." Torre is partnering with the Prostate Cancer Foundation on a new program called Women Join the TEAM Approach: Prostate Cancer Treatment, Education, Awareness and Management. The campaign urges partners and caregivers of men with prostate cancer to become active in their loved ones' treatment decisions. In particular, the program encourages men with prostate cancer to seek the advice of an integrated team of health care specialists to best determine a course of action for the disease. A TEAM Approach has become standard in treating other cancers, such as breast, colon and lung cancer, but this is currently not the case in prostate cancer. The combined expertise of various prostate cancer specialists can help men explore all available treatment options to decide upon the best course of treatment. Research has also shown that partners may enhance the quality of decision-making by gathering information, helping the patient to ask questions, or helping advise them about treatment decisions. Torre's goal is to help partners and caregivers learn from her experiences in supporting loved ones with prostate cancer. Through not only her husband's, but also her father's prostate cancer diagnosis and treatment, Torre became acutely aware of the vital role she played in their health care decisions. "Prostate cancer treatment has lagged behind other cancers where multidisciplinary teams of physicians collectively guide treatment," said Dr. James McKiernan, Assistant Professor of Urology at Columbia University Medical Center and Attending Physician at New York-Presbyterian Hospital/Columbia and a spokesman for the Women Join the TEAM Approach program. "We need to do a better job of educating men with prostate cancer not to wait until their disease has progressed to a late stage to seek the advice of a medical oncologist, and of changing our approach in the management of prostate cancer by combining the specialists early on to benefit the patient."